Randy C. EisensmithAssociate Randy C. Eisensmith, Ph.D. is a litigation associate resident in Fried Frank's New York office. He joined the Firm in 2004. Dr. Eisensmith's practice is concentrated in the field of intellectual property, including patent litigation, patent prosecution, and the drafting of patent opinions. Representative technologies include biotechnology, pharmaceuticals, chemicals, and medical and other devices. Dr. Eisensmith also litigates trademark matters in federal District Court and before the Trademark Trial and Appeal Board of the United States Patent and Trademark Office. In addition to his intellectual property practice, Dr. Eisensmith has litigated a wide range of general civil and commercial matters. Prior to joining Fried Frank, Dr. Eisensmith was a Scientific Advisor/Patent Agent from 2001 to 2004 in the New York office of a leading law firm. From 1996 to 2001, he held a primary appointment as an Associate Professor in the Institute for Gene Therapy and Molecular Medicine and a secondary appointment as an Associate Professor in the Department of Human Genetics at the Mount Sinai School of Medicine of New York University. While in academics, Dr. Eisensmith both taught graduate and medical students, and performed biomedical research. His teaching duties included gross anatomy, neuroanatomy, cell biology, molecular biology, molecular genetics, and pharmacology. The primary focus of Dr. Eisensmith's academic research was gene therapy for genetic and acquired diseases, but he also has considerable experience in molecular and population genetics, immunology, virology, cell biology, biochemistry, pharmacology and chemistry. Prior to joining the faculty of Mount Sinai, Dr. Eisensmith was a post-doctoral fellow, Assistant Professor, and Associate Professor in the Department of Cell Biology of Baylor College of Medicine in Houston, Texas from 1988 to 1996. He has authored or co-authored approximately 60 research articles in peer-reviewed journals, and has contributed articles or chapters to more than 30 scientific textbooks and monographs. Dr. Eisensmith's research group received grant support from the National Institutes of Health, the March of Dimes, the Juvenile Diabetes Foundation, the American Diabetes Association, and the American Heart Association.
|
